Watchlist Price Alert

Unicycive Therapeutics In... (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

6.59

0.65 (10.94%)

At close: Jun 27, 2025, 11:21 AM

Unicycive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-36.73M	-30.54M	-18.06M	-10.02M	-2.26M	-2.17M	-1.12M
Depreciation & Amortization	428K	284K	161K	13K	n/a	n/a	n/a
Stock-Based Compensation	2.35M	1.77M	1.05M	966K	232K	24K	n/a
Other Working Capital	-1.22M	-1.37M	-89K	-1.35M	-98K	-3K	-25K
Other Non-Cash Items	5.8M	10.3M	21K	3.25M	739K	660K	308K
Deferred Income Tax	n/a	n/a	n/a	127K	n/a	n/a	n/a
Change in Working Capital	-427K	-93K	1.18M	-105K	-166K	305K	6K
Operating Cash Flow	-28.57M	-18.28M	-15.65M	-5.77M	-1.46M	-1.18M	-775K
Capital Expenditures	-72K	-12K	-2K	-29K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-72K	-12K	-2K	-29K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	1.42M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-1.09M	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.5M	-2.65M	-482K	22.38M	-117K	1.17M	800K
Financial Cash Flow	45.09M	27.54M	-471K	22.38M	1.44M	1.17M	800K
Net Cash Flow	16.44M	9.25M	-16.12M	16.58M	-15K	-10K	25K
Free Cash Flow	-28.65M	-18.3M	-15.65M	-5.8M	-1.46M	-1.18M	-775K